SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-024879
Filing Date
2021-02-17
Accepted
2021-02-17 17:16:14
Documents
15
Period of Report
2021-02-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm217035d1_8k.htm   iXBRL 8-K 31285
2 EXHIBIT 10.1 tm217035d1_ex10-1.htm EX-10.1 77129
3 EXHIBIT 99.1 tm217035d1_ex99-1.htm EX-99.1 17422
7 GRAPHIC tm217035d1_ex99-1img001.jpg GRAPHIC 4263
  Complete submission text file 0001104659-21-024879.txt   330684

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA anip-20210211.xsd EX-101.SCH 3217
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE anip-20210211_lab.xml EX-101.LAB 34592
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE anip-20210211_pre.xml EX-101.PRE 22731
8 EXTRACTED XBRL INSTANCE DOCUMENT tm217035d1_8k_htm.xml XML 3468
Mailing Address 210 MAIN STREET WEST BAUDETTE MN 56623
Business Address 210 MAIN STREET WEST BAUDETTE MN 56623 2186343500
ANI PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-31812 | Film No.: 21646130
SIC: 2834 Pharmaceutical Preparations